Background and Objectives: Several treatments are available for sudden sensorineural hearing loss (SSNHL), but no studies have compared the different treatments based on the delay from the onset of the disease. Our study aims to compare the effect of hyperbaric oxygen therapy (HBOT), oral steroids (OS) and combination of both therapies (HBOT + OS) for treating SSNHL. Materials and Methods: This randomized study analyzed 171 patients with SSNHL. Patients were evaluated by pure tone audiometry test (PTA) at baseline (T0) and 20 days after treatment (T1). Three groups were available HBOT-A-, OS-B- and HBOT + OS-C-. After baseline PTA, patients were randomly assigned to each group. Statistical analysis was performed by one-way ANOVA and Chi-square. Results: Patients in the HBOT + OS and HBOT groups improved their auditory function (p < 0.05). HBOT was the best choice for treatment when started by 7 days from SSNHL onset, while HBOT + OS in case of late treatment. Profound SNHL recovered equally by HBOT and HBOT + OS (p < 0.05). Upsloping SNHL obtained better auditory results by HBOT compared to HBOT + OS (p < 0.05). Downsloping and flat SSNHL had the most improvement with HBOT + OS compared to HBOT only (p < 0.05). Conclusions: Combination of HBOT and OS is a valid treatment for SSNHL both in case of early and late treatment. Combination of HBOT and OS was the choice with the best results in case of treatment started >14 days from symptom onset.

Combination of hyperbaric oxygen therapy and oral steroids for the treatment of sudden sensorineural hearing loss: early or late? / Cavaliere, Matteo; DE LUCA, Pietro; Scarpa, Alfonso; Maciej Strzalkowski, Adriano; Ralli, Massimo; Calvanese, Matteo; Savignano, Luisa; Viola, Pasquale; Cassandro, Claudia; Chiarella, Giuseppe; DI STADIO, Arianna. - In: MEDICINA. - ISSN 1648-9144. - 58:10(2022). [10.3390/medicina58101421]

Combination of hyperbaric oxygen therapy and oral steroids for the treatment of sudden sensorineural hearing loss: early or late?

Matteo Cavaliere
Primo
Conceptualization
;
Pietro De Luca
Secondo
Methodology
;
Massimo Ralli
Validation
;
Arianna Di Stadio
Ultimo
Writing – Review & Editing
2022

Abstract

Background and Objectives: Several treatments are available for sudden sensorineural hearing loss (SSNHL), but no studies have compared the different treatments based on the delay from the onset of the disease. Our study aims to compare the effect of hyperbaric oxygen therapy (HBOT), oral steroids (OS) and combination of both therapies (HBOT + OS) for treating SSNHL. Materials and Methods: This randomized study analyzed 171 patients with SSNHL. Patients were evaluated by pure tone audiometry test (PTA) at baseline (T0) and 20 days after treatment (T1). Three groups were available HBOT-A-, OS-B- and HBOT + OS-C-. After baseline PTA, patients were randomly assigned to each group. Statistical analysis was performed by one-way ANOVA and Chi-square. Results: Patients in the HBOT + OS and HBOT groups improved their auditory function (p < 0.05). HBOT was the best choice for treatment when started by 7 days from SSNHL onset, while HBOT + OS in case of late treatment. Profound SNHL recovered equally by HBOT and HBOT + OS (p < 0.05). Upsloping SNHL obtained better auditory results by HBOT compared to HBOT + OS (p < 0.05). Downsloping and flat SSNHL had the most improvement with HBOT + OS compared to HBOT only (p < 0.05). Conclusions: Combination of HBOT and OS is a valid treatment for SSNHL both in case of early and late treatment. Combination of HBOT and OS was the choice with the best results in case of treatment started >14 days from symptom onset.
2022
HBOT; hyperbaric oxygen therapy; idiopathic sudden hearing loss; steroid therapy; sudden deafness
01 Pubblicazione su rivista::01a Articolo in rivista
Combination of hyperbaric oxygen therapy and oral steroids for the treatment of sudden sensorineural hearing loss: early or late? / Cavaliere, Matteo; DE LUCA, Pietro; Scarpa, Alfonso; Maciej Strzalkowski, Adriano; Ralli, Massimo; Calvanese, Matteo; Savignano, Luisa; Viola, Pasquale; Cassandro, Claudia; Chiarella, Giuseppe; DI STADIO, Arianna. - In: MEDICINA. - ISSN 1648-9144. - 58:10(2022). [10.3390/medicina58101421]
File allegati a questo prodotto
File Dimensione Formato  
Cavaliere_Combination of _2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.37 MB
Formato Adobe PDF
1.37 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1695664
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact